Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
361-02-009 ISMRM Abstract

Evaluation of PI-RADSv2.1 category 3 index lesions on follow up prostate MRI using PRECISE criteria

Primary: Body - Prostate
Secondary: Analysis Methods - Classification and Prediction
361-02-009 · Prostate: Clinical Applications, AI, and Post-Processing · Monday, 11 May, 9:15 AM–10:10 AM · Digital Posters Row B
Keywords: Prostate MRI Prostate Cancer Detection Prostate Imaging Reporting and Data System version
Accepted
Sohrab Afshari Mirak1, Kaustav Bera1,2, Leonardo K BIttencourt1,3, Yong Chen1,2,3,4,5, Sree Harsha Tirumani 1,2
1Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America
2Department of Radiology, Case Western Reserve University, Cleveland, United States of America
3University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America
4Department of Radiology, University Hospitals, Cleveland, United States of America
5Department of Biomedical Engineering, Case Western Reserve University, Cleveland, United States of America
Presenting Author: Sree Harsha Tirumani

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. “PIRADS-v2-1.pdf.” Accessed: Dec. 06, 2024. [Online]. Available: https://www.acr.org/-/media/ACR/Files/RADS/Pi-RADS/PIRADS-v2-1.pdf
2. C. Englman et al., “PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer,” Eur. Urol., vol. 86, no. 3, pp. 240–255, Sep. 2024, doi: 10.1016/j.eururo.2024.03.014. [doi]
3. B. Oerther et al., “Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis,” Radiology, vol. 312, no. 2, p. e233337, Aug. 2024, doi: 10.1148/radiol.233337 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/361-02-009